c-myc amplification is a better prognostic factor than HER2/neu amplification in primary breast cancer (Q33279432)

From Wikidata
Jump to navigation Jump to search
scientific article published on March 1, 1992
edit
Language Label Description Also known as
English
c-myc amplification is a better prognostic factor than HER2/neu amplification in primary breast cancer
scientific article published on March 1, 1992

    Statements

    c-myc amplification is a better prognostic factor than HER2/neu amplification in primary breast cancer (English)

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit